These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23818915)

  • 41. Circulating Anti-Nuclear Antibodies in Systemic Sclerosis: Utility in Diagnosis and Disease Subsetting.
    Kuwana M
    J Nippon Med Sch; 2017; 84(2):56-63. PubMed ID: 28502960
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of interferon-alpha by scleroderma sera containing autoantibodies to topoisomerase I: association of higher interferon-alpha activity with lung fibrosis.
    Kim D; Peck A; Santer D; Patole P; Schwartz SM; Molitor JA; Arnett FC; Elkon KB
    Arthritis Rheum; 2008 Jul; 58(7):2163-73. PubMed ID: 18576347
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical setting of patients with systemic sclerosis by serum autoantibodies.
    Picillo U; Migliaresi S; Marcialis MR; Ferruzzi AM; Tirri G
    Clin Rheumatol; 1997 Jun; 16(4):378-83. PubMed ID: 9259252
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis.
    Bunn CC; Denton CP; Shi-Wen X; Knight C; Black CM
    Br J Rheumatol; 1998 Jan; 37(1):15-20. PubMed ID: 9487245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect.
    Srivastava N; Hudson M; Tatibouet S; Wang M; Baron M; Fritzler MJ;
    Semin Arthritis Rheum; 2015 Oct; 45(2):184-9. PubMed ID: 25959492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Undifferentiated connective tissue diseases: the clinical and serological profiles of 91 patients followed for at least 1 year.
    Mosca M; Tavoni A; Neri R; Bencivelli W; Bombardieri S
    Lupus; 1998; 7(2):95-100. PubMed ID: 9541093
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autoantibodies in systemic sclerosis (scleroderma): clues for clinical evaluation, prognosis and pathogenesis.
    Grassegger A; Pohla-Gubo G; Frauscher M; Hintner H
    Wien Med Wochenschr; 2008; 158(1-2):19-28. PubMed ID: 18286246
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis.
    Costa S; Mondini M; Caneparo V; Afeltra A; Airò P; Bellisai F; Faggioli P; Gerli R; Lotzniker M; Meroni PL; Morozzi G; Radice A; Riccieri V; Scarsi M; Sebastiani GD; Sinico RA; Tincani A; Gariglio M; Landolfo S
    Rheumatology (Oxford); 2011 Apr; 50(4):674-81. PubMed ID: 21134960
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-Scl-70 (topo-I) antibodies in SLE: Myth or reality?
    Mahler M; Silverman ED; Schulte-Pelkum J; Fritzler MJ
    Autoimmun Rev; 2010 Sep; 9(11):756-60. PubMed ID: 20601198
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Autoantibodies in systemic sclerosis: clinical interest and diagnosis approach].
    Admou B; Essaadouni L; Amal S; Arji N; Chabaa L; El Aouad R
    Ann Biol Clin (Paris); 2009; 67(3):273-81. PubMed ID: 19411229
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Significance of combined anti-CCP antibodies and rheumatoid factor in a New Zealand cohort of patients with systemic sclerosis.
    Kamalaksha S; White DHN; Solanki KK
    Int J Rheum Dis; 2018 Jul; 21(7):1430-1435. PubMed ID: 29968328
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiac involvement in undifferentiated connective tissue disease at risk for systemic sclerosis (otherwise referred to as very early-early systemic sclerosis): a TDI study.
    D'Alto M; Riccardi A; Argiento P; Di Stefano I; Romeo E; Iacono AM; D'Andrea A; Fasano S; Sanduzzi A; Bocchino M; Docimo L; Tolone S; Russo MG; Valentini G
    Clin Exp Med; 2018 May; 18(2):237-243. PubMed ID: 28993902
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early systemic sclerosis: analysis of the disease course in patients with marker autoantibody and/or capillaroscopic positivity.
    Valentini G; Marcoccia A; Cuomo G; Vettori S; Iudici M; Bondanini F; Santoriello C; Ciani A; Cozzolino D; De Matteis GM; Cappabianca S; Vitelli F; Spanò A
    Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1520-7. PubMed ID: 24515450
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Autoantibodies as predictive tools in systemic sclerosis.
    Nihtyanova SI; Denton CP
    Nat Rev Rheumatol; 2010 Feb; 6(2):112-6. PubMed ID: 20125179
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma.
    Ceribelli A; Cavazzana I; Franceschini F; Airò P; Tincani A; Cattaneo R; Pauley BA; Chan EK; Satoh M
    J Rheumatol; 2010 Oct; 37(10):2071-5. PubMed ID: 20682663
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects.
    Diab S; Dostrovsky N; Hudson M; Tatibouet S; Fritzler MJ; Baron M; Khalidi N;
    J Rheumatol; 2014 Nov; 41(11):2179-85. PubMed ID: 25274885
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Soluble P selectin in systemic sclerosis: relationship with von Willebrand factor, autoantibodies and diffuse or localised/limited disease.
    Blann AD; Constans J; Carpentier P; Renard M; Satger B; Guérin V; Boisseau MR; Neau-Cransac N; Conri C
    Thromb Res; 2003 Feb; 109(4):203-6. PubMed ID: 12757775
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical and serological features of systemic sclerosis in a Chinese cohort.
    Wang J; Assassi S; Guo G; Tu W; Wu W; Yang L; Xiao R; Zhao Y; Chu H; Liu J; Ma Y; Kim SJ; Jin L; Mayes MD; Zou H; Zhou X
    Clin Rheumatol; 2013 May; 32(5):617-21. PubMed ID: 23271609
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autoantibodies to angiotensin-converting enzyme 2 in patients with connective tissue diseases.
    Takahashi Y; Haga S; Ishizaka Y; Mimori A
    Arthritis Res Ther; 2010; 12(3):R85. PubMed ID: 20470389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.